Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term 'Eye' refers to a complex physiological organ responsible for vision and light perception rather than a specific molecular target such as a protein, enzyme, or receptor. In the context of pharmacology and drug discovery, a target must be a discrete molecular entity that a drug binds to, whereas the eye serves as the anatomical site of action or delivery for various ophthalmic therapies. While the eye contains numerous valid therapeutic targets—including vascular endothelial growth factor (VEGF) for macular degeneration or beta-adrenergic receptors for glaucoma—the organ itself cannot be classified as a singular target. Consequently, this entry is categorized as incorrect or too broad for structured biochemical target analysis.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eye.